QC
CLB icon

Quantessence Capital’s Core Laboratories CLB Stock Holding History

Quantessence Capital’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,560
Closed -$192K – 46
2025
Q3 		$192K Buy
+15,560
New +$182K 0.06% 162

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Quantessence Capital's CLB Position: Q4 2025 in Review

Quantessence Capital sold out of Core Laboratories (CLB) in Q4 2025, closing a stake of 15,560 shares — an estimated $192K sold.

Quantessence Capital first reported a position in CLB in Q3 2025 and held it in 1 quarter. The position peaked at $192K in Q3 2025. 187 funds tracked by Wall St. Rank hold CLB as of Q4 2025.

  • Quantessence Capital reported no remaining Core Laboratories position as of Q4 2025 after selling out during the quarter.
  • Quantessence Capital sold 15,560 Core Laboratories shares in Q4 2025, an estimated $192K.
  • Quantessence Capital first reported a position in Core Laboratories in Q3 2025 and held it in 1 quarter.
  • Quantessence Capital's Core Laboratories position peaked at $192K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2025.

Based on Quantessence Capital's 13F filing for Q4 2025, filed 17 Feb 2026.